Stamford, Connecticut-based Purdue Pharma has announced leadership changes that include adding veteran Marc Kesselman as senior vice president and general counsel.

Privately held Purdue, maker of the popular opioid Oxycontin, has been under heavy criticism recently amid local, state and federal governments’ legal attacks on pharma companies for their role in promoting opioid abuse and addiction.